Neuphoria Therapeutics Inc.
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NEUP and other ETFs, options, and stocks.About NEUP
Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. It focuses on developing BNC210, an oral drug designed for the acute treatment of social anxiety disorder (SAD) and the chronic treatment of post-traumatic stress disorder (PTSD) by selectively targeting the a7 nicotinic acetylcholine receptor.
NEUP Key Statistics
Stock Snapshot
The current Neuphoria Therapeutics Inc.(NEUP) stock price is $5.38, with a market capitalization of 29.69M. The stock trades at a price-to-earnings (P/E) ratio of -0.23.
On 2026-05-06, Neuphoria Therapeutics Inc.(NEUP) stock moved within a range of $5.34 to $5.45. With shares now at $5.38, the stock is trading +0.8% above its intraday low and -1.3% below the session's peak.
Trading activity shows a volume of 27.26K, compared to an average daily volume of 27.23K.
Over the past 52 weeks, Neuphoria Therapeutics Inc.(NEUP) stock has traded between a high of $21.40 and a low of $3.65.
Over the past 52 weeks, Neuphoria Therapeutics Inc.(NEUP) stock has traded between a high of $21.40 and a low of $3.65.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.